Published 5 days ago • loading... • Updated 5 days ago
"This Is Unacceptable": Bayer CEO Expects Europe's Pharmaceutical Policy
Summary
Stem cell therapies, trade war, Middle East crisis: Bayer CEO Bill Anderson talks to t-online about the future of medicine, the risks and opportunities for the global pharmaceutical and chemical company.
Bayer CEO Bill Anderson sees Germany in a deep crisis: too expensive, too slow, too bureaucratic. Nevertheless, the US manager believes in the location. In an interview, he explains why he remains optimistic despite all the crises.
Bayer CEO Bill Anderson sees Germany under increasing pressure in international competition. High energy costs, bureaucracy, and non-wage labor costs are significant disadvantages for the country as a business location.
According to Bayer CEO Bill Anderson, Germany suffers from a competitive disadvantage due to high energy costs and excessive bureaucracy. He nevertheless had praise for Friedrich Merz, but believes the country needs an inspiring mission.